LMRA Lumera Corpration (MM)

Lumera Corporation (Nasdaq:LMRA), an emerging leader in the field of nanotechnology, announced today that Sanjiv Sam Gambhir, MD, Ph.D. has joined its Board of Directors. Since 2003, Dr. Gambhir has served concurrently as Professor, Departments of Radiology and Bioengineering and Division Chief, Nuclear Medicine Division at Stanford University School of Medicine and Director, Molecular Imaging Program at Stanford (MIPS) (http://mips.stanford.edu). "The technologies being developed at Lumera have enormous potential for accelerating many areas of biomedical research as they are now deployed. I am very excited to be joining Lumera at a time when biomedical applications of its proprietary technologies should be a key component of its exciting growth," said Dr. Gambhir. Dr. Gambhir's focus is on cancer biology and multimodality molecular imaging. In particular, his research is aimed at developing imaging assays to monitor fundamental cellular events in living subjects. By marrying fundamental advances in molecular/cell biology with those in biomedical imaging, further progress in the field of molecular imaging can be achieved. "We are extremely proud to have someone of Dr. Gambhir's caliber on our Board. His knowledge of bioscience will help Lumera correctly position itself in the developing field of proteomics," said Tom Mino, Lumera's Chief Executive Officer. From 2001 to 2003 Dr. Gambhir served as Director, Crump Institute for Molecular Imaging and Vice-Chair of Molecular & Medical Pharmacology, University of California Los Angeles School of Medicine. Dr. Gambhir has a B.S. in Physics from Arizona State University and an M.D. and Ph.D. from University of California, Los Angeles. About Lumera Lumera is an emerging leader in the field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com. Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K, and its Quarterly Reports on Form 10-Q.